CrushSCI.com
124平均天数
122中位天数
30最短天数
327最长天数
2542025发文量

Paper Review Records

全部论文审稿周期

29 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

158 天

Disparities in Treatment Patterns for Advanced ALK ‐ and EGFR ‐Mutated Non‐Small Cell Lung Cancer Patients in Mexico

作者
Luis Arturo Sanchez Trujillo; Diego Armando Díaz García; Ida Caterina García‐Appendini; Nohemi Caballero; Nils Ramirez Knape; Sandra Evangelina Herrera; Jose Francisco Olguin; Guilherme Silva Julian展开收起
作者单位
1. Pfizer México Mexico City Mexico; 2. Oncology Department Hospital Ángeles Del Carmen Guadalajara Jalisco Mexico; 3. Real World Insights (RWI), IQVIA Ciudad de Mexico Mexico; 4. Real World Insights (RWI), IQVIA Bogotá Colombia; 5. Evidence Generation Emerging Markets Pfizer São Paulo Brazil展开收起
PDF源文件 DOI 网页
150 天

Transesophageal Endoscopic Ultrasound With Bronchoscope‐Guided Fine‐Needle Aspiration for Tissue Diagnosis of Pleural Malignancy in a Patient With Respiratory Compromise

作者
So‐Yun Kim; Chaeuk Chung; Dongil Park展开收起
作者单位
1. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine Chungnam National University Hospital Daejeon Republic of Korea; 2. Department of Internal Medicine College of Medicine, Chungnam National University Daejeon Republic of Korea展开收起
PDF源文件 DOI 网页
137 天

Prognostic Value of Early Dynamic Changes in Skeletal Muscle Index for Unresectable Lung Squamous Cell Carcinoma: A Prospective Landmark Analysis

作者
Xinjie Zhang; Xueni Liu; Chenglan Ye; Yixiao Fu; Jie Chen; Minhua Wu; Jianhui Huang; Yanru Xie展开收起
作者单位
1. Department of Cancer Center The Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Central Hospital) Lishui China展开收起
PDF源文件 DOI 网页
51 天

Protocol of a Real‐World Prospective Observational Study of Amivantamab Plus Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Non‐Small Cell Lung Cancer ( SPIRAL ‐ RACER20 Study)

作者
Ryo Sawada; Tadaaki Yamada; Takayuki Shimose; Masaki Ishida; Hayato Kawachi; Naoya Nishioka; Masahiro Iwasaku; Shinsaku Tokuda; Tohru Inaba; Koichi Takayama展开收起
作者单位
1. Department of Pulmonary Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan; 2. Department of Statistics and Data Center Clinical Research Support Center Kyushu Fukuoka Japan; 3. Kyoto Prefectural Institute of Public Health and Environment Kyoto Japan; 4. Department of Infection Control and Laboratory Medicine Kyoto Prefectural University of Medicine Kyoto Japan展开收起
PDF源文件 DOI 网页
260 天

Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report

作者
Bingyu Huang; Tao Lu; Ruping Hong; Xiaoyan Liu; Xiaoxing Gao; Yan Xu; Minjiang Chen; Wei Zhong; Mengzhao Wang; Jing Zhao展开收起
作者单位
1. Department of Internal Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China; 2. Department of Pathology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China; 3. Department of Pulmonary and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China展开收起
PDF源文件 DOI 网页
111 天

Exhaled Breath Analysis for Lung Cancer Detection: From VOCs Signatures to EBC ‐Based Liquid Biopsy and Clinical Translation

作者
Penghai Sun; Zhenkai Fu; Shaodong Wang; Yun Li; Mantang Qiu展开收起
作者单位
1. Department of Thoracic Surgery Peking University People's Hospital Beijing China; 2. Thoracic Oncology Institute Peking University People's Hospital Beijing China; 3. Research Unit of Intelligence Diagnosis and Treatment in Early Non‐Small Cell Lung Cancer Chinese Academy of Medical Sciences, 2021RU002 Beijing China; 4. Institute of Advanced Clinical Medicine Peking University Beijing China; 5. Frontiers Science Center for Cancer Integrative Omics Peking University People's Hospital Beijing China展开收起
PDF源文件 DOI 网页

FAQ

Thoracic Cancer审稿要多久?

截至2026-11-18,CrushSCI 收录了 Thoracic Cancer 的 29 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(Delayed Occurrence of Lung Cancer Leptomeningeal Metastasis and Era‐Associated Post‐ LM Survival: A 14‐Year Single‐Center Cohort Study,2026-07-19 收稿,2026-08-18 录用),最慢一篇用了 327 天;平均 124 天,中位数 122 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。